E-Mail Alert

Add your e-mail address to receive forthcoming issues of this journal:

Journal Browser

Journal Browser

Special Issue "Marine Compounds in Neurodegenerative Diseases"

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: 31 May 2018

Special Issue Editors

Guest Editor
Prof. Dr. Patrizia Russo

IRCCS San Raffaele Pisana, Area of Clinical and Molecular Epidemiology, 00166 Rome, Italy
Interests: Applied biology,nicotinic receptor in cancer, COPD, addiction, Alzheimer, systems medicine
Guest Editor
Prof. Dr. Massimo Fini

Scientific Direction, IRCCS San Raffaele Pisana, Rome, Italy
Phone: 06-6613-0405
Interests: Systems medicine, aging, frailty, rehabilitation, cardiovascular

Special Issue Information

Dear Colleagues,

Aging-associated neurodegenerative diseases (NDs), such as Alzheimer's disease (AD) and AD-like pathologies, such as changes in Aβ40/42 ratios, tau hyperphosphorylation and endosome abnormalities, Parkinson's disease (PD), frontotemporal degeneration (FTD) and amyotrophic lateral sclerosis (ALS), among others, are unremittingly progressive and fatal neurological diseases. NDs are characterized by irreversible loss of neurons/cholinergic or dopaminergic receptors functionality that results in apoptosis and, in turn, in severe atrophy of the affected patient brain regions. Pathogenesis of NDs are complex and the underlying mechanisms are yet to be fully explored.

Neurodegeneration is associated to neuroinflammation a dynamic biological response characterized by the recruitment of innate and adaptive immune system cells in the site of tissue damage. Activation of resident microglia and infiltrating immune cells may contribute to the disease process itself.

This Special Issue “Marine Compounds in Neurodegenerative Diseases” of Marine Drugs will cover the whole scope of agents targeting the mechanisms underlying NDs. This Special issue is focused on (but not limited to) compounds with relevant biological activities; however, preclinical drugs are also investigated.

Prof. Dr. Patrizia Russo
Prof. Dr. Massimo Fini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • neurodegenerative diseases
  • neuroinflammation
  • marine compounds
  • cell death
  • cell survival
  • drug resistance
  • necrosis

Published Papers

This special issue is now open for submission.

Journal Contact

Marine Drugs Editorial Office
St. Alban-Anlage 66, 4052 Basel, Switzerland
Tel. +41 61 683 77 34
Fax: +41 61 302 89 18
Editorial Board
Contact Details Submit to Special Issue Edit a special issue Review for Marine Drugs
Back to Top